Rybrevant may be considered medically necessary in patients 18 years of age or older for the treatment of with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations and if the conditions indicated below are met.
Localización de Nuestra Oficina principal:
Dirección Física:
1441 F.D. Roosevelt Ave.
San Juan, P.R. 00936
Dirección Postal:
P.O. Box 363628
San Juan, P.R. 00936-3628